Outcomes of patients with end-stage renal disease (ESRD) under chronic hemodialysis requiring continuous renal replacement therapy (CRRT) and patients without ESRD in acute kidney injury requiring CRRT: A single-center study
Hemodialysis International, 05/02/2012Jung YS et al.
The survival rates of non–end–stage renal disease (ESRD) and ESRD patients requiring continuous renal replacement therapy did not differ; ESRD with conventional hemodialysis patients may be not a significant predictor of mortality.
The authors evaluated adults (>18 years) requiring CRRT who were treated in the intensive care unit (ICU) at Kosin University Gospel Hospital from January 1, 2009 to December 31, 2010.
A total of 100 (24 ESRD, 76 non-ESRD) patients underwent CRRT during the study period.
Patients were divided into two major groups: patients with ESRD requiring chronic dialysis and patients without ESRD (non-ESRD) with AKI.
The authors compared the survival of conventional HD patients requiring CRRT with the survival of non- ESRD patients in AKI requiring CRRT.
For non-ESRD patients, the 90-day survival rate was 41.6%.
For ESRD patients, the 90-day survival rate was 55.3%.
Multivariate Cox proportional hazards analyses demonstrated that conventional HD was not a significant predictor of mortality (hazard ratio [HR]: 0.334, 95% confidence interval [CI]: 0.063-1.763, P = 0.196), after adjustment for age, gender, presence of sepsis, APACHE score, use of vasoactive drugs, number of organ failures, ultrafiltration rate, and arterial pH.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.